Uncertain role of increased intensity chemotherapy with high-dose cytarabine in acute promyelocytic leukemia.

Authors :: Sanz, M A
Martin, G
Rayón, C
Debén, G
Tormo, M
Díaz-Mediavilla, J
Esteve, J
González-San Miguel, J D
Spanish PETHEMA Cooperative Group
Source :: Leukemia (08876924). Dec2001, Vol. 15 Issue 12, p1999-2002. 4p.
Publication Year :: 2001
Abstract: Discusses the role of increased intensity chemotherapy with high-dose cytarabine in acute promyelocytic leukemia (APL). Factors that influence the outcome of APL; Reasons for exploring the possibility of reducing treatment intensity; Comments on the molecular remission rate after induction and consolidation.

Subjects :: *DRUG therapy
*ACUTE myeloid leukemia
*DOSE-effect relationship in pharmacology
*TREATMENT effectiveness
*ACUTE promyelocytic leukemia
*CYTARABINE
*THERAPEUTICS

Tools